维普期刊资源整合服务平台（V6.5）

242篇 您的检索式：作者名="Salgia"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	c-Met: Structure, functions and potential for therapeutic inhibition显示文摘	Patrick C. Ma Gautam Maulik James Christensen Ravi Salgia	2003	Cancer and Metastasis Reviews2003，，4：	2
2	Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification显示文摘	Sai-Hong Ignatius Ou Eunice L. Kwak Christina Siwak-Tapp Joni Dy Kristin Bergethon Jeffrey W. Clark D. Ross Camidge Benjamin J. Solomon Robert G. Maki Yung-Jue Bang Dong-Wan Kim James Christensen Weiwei Tan Keith D. Wilner Ravi Salgia A. John Iafrate	2011	Journal of Thoracic Oncology2011，，5：	2
3	Role of receptor tyrosine kinase in lung cancer显示文摘	Maulik G Kijima T Salgia R	2003	Methods Mol Med2003，74，1：	2
4	Biomarker discovery in lung cancer-promises and challenges of clinical proteomics 显示文摘	BHARTI A MAP C SALGIA R	2007	Mass Spectrom Rev2007，26，3：	1
5	c- Met as a target for human cancer and characterization of inhibitors for therapeutic intervention 显示文摘	Christensen J G Burrows J Salgia R	2005	Cancer Lett2005，225，1：	1
6	c-Met as a possible target for non-small-cell lung cancer显示文摘	Sadiq A A Salgia R	2013	J Clin Oneol2013，31，8：	1
7	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
8	Role of c-Met in cancer: emphasis on lung cancer显示文摘	Salgia R	2009	Semin Onco2009，36，2：	1
9	Biomarkers in lung cancer: from early detection to novel therapeutics and decision making显示文摘	Scott A Salgia R	2008	Biomark Med2008，2，6：	1
10	Role of serum tumor markers CA125 and CEA in no-small cell lung cancer 显示文摘	Salgia R Harpole D Hemdon JE	2001	Anti- cancer Res2001，21，2：	1
11	Personalized treatment of lung cancer显示文摘	Salgia R Hensing T Campbell N	2011	Semin Oncol2011，38，2：	1
12	Role of serum tumour markers CA- 125 and CEA in non -small cell lung cancer显示文摘	Salgia R Harpole D Hernkon J	2001	Anticancer Res2001，21，2：	1
13	Targeted agents in non-small celllung cancer therapy: What is there on the horizon显示文摘	Villaflor VM Salgia R	2013	Car-cinog2013，12，：	1
14	Molecular and cellular biology of small cell lung cancer 显示文摘	Sattler M Salgia R	2003	Semin Oncol2003，30，：	1
15	Lung carcinoma in African Americans 显示文摘	Abidoye O Ferguson M K Salgia R	2007	Nat Clin Pract Oncol2007，4，2：	1
16	Phase 2 trial of Linifanib (ABT-869) in patients with advaneed non- small cell lung cancer 显示文摘	Tan E H Goss G D Salgia R	2011	J Thorac Oncol2011，6，8：	1
17	Role of serum tumor markers CA125 and CEA in non-small cell lung cancer显示文摘	Salgia R Harpole D Herndon JE	2001	Anticancer Res2001，21，2：	1
18	Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma显示文摘	SALGIA R LYNCH T SKARIN A		J0，，：	1
19	The MET axis as a therapeutic target显示文摘	Sattler M Salgia R	2009	Update Cancer Ther2009，3，3：	1
20	CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer显示文摘	Sharma S Dubinett S Salgia R		0，，10：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示